Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Role of colesevelam in managing heterozygous familial hypercholesterolemia in adolescents and children.

Sonnett T, Robinson J, Milani P, Campbell RK.

Adolesc Health Med Ther. 2010 Aug 4;1:53-60. eCollection 2010. Review.

2.

Established and emerging approaches for the management of dyslipidaemia.

Norata GD.

Scientifica (Cairo). 2012;2012:482423. doi: 10.6064/2012/482423. Epub 2012 Sep 10. Review.

3.

Role of colesevelam in combination lipid-lowering therapy.

Jones MR, Nwose OM.

Am J Cardiovasc Drugs. 2013 Oct;13(5):315-23. doi: 10.1007/s40256-013-0037-0. Review.

4.

Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol.

Wang HH, Portincasa P, de Bari O, Liu KJ, Garruti G, Neuschwander-Tetri BA, Wang DQ.

Eur J Clin Invest. 2013 Apr;43(4):413-26. doi: 10.1111/eci.12058. Epub 2013 Feb 19. Review.

6.
7.

Safety of simvastatin and goal attainment for low-density lipoprotein cholesterol in sultan qaboos university hospital.

Al-Siyabi K, Farhan H, Al-Rasadi K, Al-Salhi A, Al-Hinai AT, Al-Zakwani I.

Oman Med J. 2010 Oct;25(4):264-8. doi: 10.5001/omj.2010.79.

8.

Role of bile acid sequestrants in the treatment of type 2 diabetes.

Takebayashi K, Aso Y, Inukai T.

World J Diabetes. 2010 Nov 15;1(5):146-52. doi: 10.4239/wjd.v1.i5.146.

10.

Treatment of dyslipidemia in patients with type 2 diabetes.

Vijayaraghavan K.

Lipids Health Dis. 2010 Dec 20;9:144. doi: 10.1186/1476-511X-9-144. Review.

11.

LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives.

Al-Allaf FA, Coutelle C, Waddington SN, David AL, Harbottle R, Themis M.

Int Arch Med. 2010 Dec 13;3:36. doi: 10.1186/1755-7682-3-36.

12.

Bile acid sequestrants for lipid and glucose control.

Staels B, Handelsman Y, Fonseca V.

Curr Diab Rep. 2010 Feb;10(1):70-7. doi: 10.1007/s11892-009-0087-5.

13.

Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence.

Fonseca VA, Handelsman Y, Staels B.

Diabetes Obes Metab. 2010 May;12(5):384-92. doi: 10.1111/j.1463-1326.2009.01181.x. Review.

15.

Effectiveness of combined statin plus omega-3 fatty acid therapy for mixed dyslipidemia.

Barter P, Ginsberg HN.

Am J Cardiol. 2008 Oct 15;102(8):1040-5. doi: 10.1016/j.amjcard.2008.05.056. Epub 2008 Jul 31. Review. Erratum in: Am J Cardiol. 2009 Feb 1;103(3):435.

Supplemental Content

Support Center